Inventor · disambiguated record
Hans J. Hansen
Also filed as: HANSEN HANS · HANSEN HANS J · HANSEN HANS JOHN
187 granted patents·58 pending applications·8,737 citations·filing 1974–2019
99Inventor score
Files withIMMUNOMEDICS INC193GOLDENBERG DAVID M16HANSEN HANS J10HOFFMANN LA ROCHE5IBC PHARMACEUTICALS INC4
Top patents by PatentIndex Score
245 records- 0199US7931903B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2010·Granted Apr 26, 2011·97 cites·38 claims
- 0299US7772373B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Aug 10, 2010·114 cites·35 claims
- 0399US7662378B2Antibody therapyIMMUNOMEDICS INC·Filed 2007·Granted Feb 16, 2010·73 cites·18 claims
- 0499US7641901B2Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2005·Granted Jan 5, 2010·76 cites·47 claims
- 0599US7312318B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 25, 2007·243 cites·23 claims
- 0699US7109304B2Humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2004·Granted Sep 19, 2006·240 cites·4 claims
- 0799US7074403B1Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2000·Granted Jul 11, 2006·226 cites·20 claims
- 0899US4925648ADetection and treatment of infectious and inflammatory lesionsIMMUNOMEDICS INC·Filed 1988·Granted May 15, 1990·518 cites·16 claims
- 0998US9187561B2Humanized anti-HLA-DR antibodiesIMMUNOMEDICS INC·Filed 2014·Granted Nov 17, 2015·35 cites·21 claims
- 1098US8992917B2Humanized L243 antibodiesIMMUNOMEDICS INC·Filed 2013·Granted Mar 31, 2015·37 cites·23 claims
- 1198US8084583B2RS7 antibodiesGOVINDAN SERENGULAM V·Filed 2009·Granted Dec 27, 2011·44 cites·28 claims
- 1298US7902338B2Anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2008·Granted Mar 8, 2011·47 cites·11 claims
- 1398US7541440B2Chimeric, human and humanized anti-granulocyte antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Jun 2, 2009·129 cites·24 claims
- 1498US7462352B2Methods of treatng B-cell diseases using humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2006·Granted Dec 9, 2008·74 cites·21 claims
- 1598US7300655B2Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereofIMMUNOMEDICS INC·Filed 2003·Granted Nov 27, 2007·109 cites·19 claims
- 1698US7282567B2Monoclonal antibody hPAM4IMMUNOMEDICS INC·Filed 2003·Granted Oct 16, 2007·143 cites·43 claims
- 1798US7238785B2RS7 antibodiesIMMUNOMEDICS INC·Filed 2003·Granted Jul 3, 2007·237 cites·8 claims
- 1898US7151164B2Anti-CD20 antibodies and fusion proteins thereof and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 19, 2006·290 cites·16 claims
- 1998US6962702B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Nov 8, 2005·126 cites·30 claims
- 2098US6187287B1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1998·Granted Feb 13, 2001·402 cites·34 claims
- 2198US5789554AImmunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1996·Granted Aug 4, 1998·596 cites·32 claims
- 2298US5443953APreparation and use of immunoconjugatesIMMUNOMEDICS INC·Filed 1993·Granted Aug 22, 1995·338 cites·17 claims
- 2397US9180205B2Stable compositions of high-concentration allotype-selected antibodies for small-volume administrationIMMUNOMEDICS INC·Filed 2014·Granted Nov 10, 2015·52 cites·23 claims
- 2497US8722047B2Humanized anti-HLA-DR antibodiesGOLDENBERG DAVID M·Filed 2010·Granted May 13, 2014·33 cites·19 claims
- 2597US8613903B2Humanized L243 antibodiesGOLDENBERG DAVID M·Filed 2009·Granted Dec 24, 2013·35 cites·20 claims
- 2697US8361464B2Anthracycline-Antibody Conjugates for Cancer TherapyIMMUNOMEDICS INC·Filed 2009·Granted Jan 29, 2013·18 cites·8 claims
- 2797US8287865B2Class I anti-CEA antibodies and uses thereofHANSEN HANS J·Filed 2010·Granted Oct 16, 2012·37 cites·66 claims
- 2897US8119101B2Anti-CD74 immunoconjugates and methods of useBYRD JOHN C·Filed 2010·Granted Feb 21, 2012·92 cites·34 claims
- 2997US7919087B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Apr 5, 2011·33 cites·18 claims
- 3097US7612180B2Humanized L243 antibodiesIMMUNOMEDICS INC·Filed 2006·Granted Nov 3, 2009·102 cites·25 claims
- 3197US7501498B2Alpha-fetoprotein Immu31 antibodies and fusion proteinsIMMUNOMEDICS INC·Filed 2007·Granted Mar 10, 2009·16 cites·26 claims
- 3297US7011812B1Targeted combination immunotherapy of cancer and infectious diseasesIMMUNOMEDICS INC·Filed 2000·Granted Mar 14, 2006·64 cites·51 claims
- 3397US6254868B1Glycosylated humanized B-cell specific antibodiesIMMUNOMEDICS INC·Filed 1997·Granted Jul 3, 2001·206 cites·12 claims
- 3497US5874540ACDR-grafted type III anti-CEA humanized mouse monoclonal antibodiesIMMUNOMEDICS INC·Filed 1994·Granted Feb 23, 1999·201 cites·30 claims
- 3596US9475883B2Therapeutic use of anti-CD22 antibodies for inducing trogocytosisIMMUNOMEDICS INC·Filed 2015·Granted Oct 25, 2016·10 cites·13 claims
- 3696US8658773B2Ultrafiltration concentration of allotype selected antibodies for small-volume administrationZENG LI·Filed 2012·Granted Feb 25, 2014·46 cites·18 claims
- 3796US7951369B2Chimeric, human and humanized anti-granulocyte antibodies and methods of useIMMUNOMEDICS INC·Filed 2009·Granted May 31, 2011·31 cites·28 claims
- 3896US7534427B2Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteinsIMMUNOMEDICS INC·Filed 2003·Granted May 19, 2009·86 cites·44 claims
- 3996US7517964B2RS7 antibodiesIMMUNOMEDICS INC·Filed 2007·Granted Apr 14, 2009·68 cites·14 claims
- 4096US7138103B2Use of bi-specific antibodies for pre-targeting diagnosis and therapyIMMUNOMEDICS INC·Filed 2002·Granted Nov 21, 2006·65 cites·36 claims
- 4196US6926893B1Multi-stage cascade boosting vaccineIMMUNOMEDICS INC·Filed 2000·Granted Aug 9, 2005·50 cites·6 claims
- 4296US6077499ATargeted combination immunotherapy of cancerIMMUNOMEDICS INC·Filed 1998·Granted Jun 20, 2000·304 cites·37 claims
- 4396US5922302ADetection and therapy of lesions with biotin/avidin-metal chelating protein conjugatesIMMUNOMEDICS INC·Filed 1995·Granted Jul 13, 1999·165 cites·36 claims
- 4495US10111954B2Combination therapy for inducing immune response to diseaseIBC PHARMACEUTICALS INC·Filed 2016·Granted Oct 30, 2018·8 cites·13 claims
- 4595US8758752B2RS7 antibodiesIMMUNOMEDICS INC·Filed 2013·Granted Jun 24, 2014·16 cites·17 claims
- 4695US8216572B2Antibody therapyGOLDENBERG DAVID M·Filed 2011·Granted Jul 10, 2012·8 cites·19 claims
- 4795US8062636B2Antibody therapyGOLDENBERG DAVID M·Filed 2011·Granted Nov 22, 2011·11 cites·21 claims
- 4895US7435803B2Anti-CD20 antibodies and fusion proteins thereof and methods of useIMMUNOMEDICS INC·Filed 2006·Granted Oct 14, 2008·32 cites·26 claims
- 4995US7414121B2Chimeric, human and humanized anti-CSAp monoclonal antibodiesIMMUNOMEDICS INC·Filed 2005·Granted Aug 19, 2008·16 cites·3 claims
- 5095US5736119ADetection and therapy of lesions with biotin/avidin-metal chelating protein conjugatesIMMUNOMEDICS INC·Filed 1995·Granted Apr 7, 1998·130 cites·27 claims
Showing the top 50 of 245 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hans J. Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →